Howard Hughes Medical Institute, Department of Molecular Biology and Center for Computational and Integrative Biology, Massachusetts General Hospital, 185 Cambridge Street, Boston, Massachusetts 02114, USA.
Department of Chemistry and Chemical Biology, Harvard University, 12 Oxford Street, Cambridge, Massachusetts 02138, USA.
Nucleic Acids Res. 2022 Jan 11;50(1):35-45. doi: 10.1093/nar/gkab1202.
The identification of nonenzymatic pathways for nucleic acid replication is a key challenge in understanding the origin of life. We have previously shown that nonenzymatic RNA primer extension using 2-aminoimidazole (2AI) activated nucleotides occurs primarily through an imidazolium-bridged dinucleotide intermediate. The reactive nature and preorganized structure of the intermediate increase the efficiency of primer extension but remain insufficient to drive extensive copying of RNA templates containing all four canonical nucleotides. To understand the factors that limit RNA copying, we synthesized all ten 2AI-bridged dinucleotide intermediates and measured the kinetics of primer extension in a model system. The affinities of the ten dinucleotides for the primer/template/helper complexes vary by over 7,000-fold, consistent with nearest neighbor energetic predictions. Surprisingly, the reaction rates at saturating intermediate concentrations still vary by over 15-fold, with the most weakly binding dinucleotides exhibiting a lower maximal reaction rate. Certain noncanonical nucleotides can decrease sequence dependent differences in affinity and primer extension rate, while monomers bridged to short oligonucleotides exhibit enhanced binding and reaction rates. We suggest that more uniform binding and reactivity of imidazolium-bridged intermediates may lead to the ability to copy arbitrary template sequences under prebiotically plausible conditions.
确定非酶促核酸复制途径是理解生命起源的关键挑战。我们之前已经表明,使用 2-氨基咪唑(2AI)激活核苷酸的非酶促 RNA 引物延伸主要通过咪唑桥联二核苷酸中间体发生。中间体的反应性和预组织结构提高了引物延伸的效率,但仍不足以驱动包含所有四个典型核苷酸的 RNA 模板的广泛复制。为了了解限制 RNA 复制的因素,我们合成了所有十个 2AI 桥连二核苷酸中间体,并在模型系统中测量了引物延伸的动力学。十种二核苷酸与引物/模板/辅助复合物的亲和力差异超过 7000 倍,与最近邻能量预测一致。令人惊讶的是,在饱和中间浓度下的反应速率仍然相差超过 15 倍,结合最弱的二核苷酸表现出较低的最大反应速率。某些非典型核苷酸可以降低序列依赖性亲和力和引物延伸速率的差异,而与短寡核苷酸桥接的单体则表现出增强的结合和反应速率。我们认为,咪唑桥连中间体更均匀的结合和反应性可能导致在具有生物前合理性的条件下复制任意模板序列的能力。